KAREN CHEN: Open Payments
NPI 1891374963 · FREMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,101 in 81 payments from 15 companies in 2025. Trend: 2023 $2,888 · 2024 $5,092 · 2025 $3,101
Food & beverage: $3,091Education: $10
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 5 | $422 |
| Incyte Corporation | 10 | $413 |
| LEO Pharma Inc. | 14 | $413 |
| Galderma Laboratories, L.P. | 8 | $373 |
| ABBVIE INC. | 8 | $296 |
| Arcutis Biotherapeutics, Inc. | 11 | $199 |
| PFIZER INC. | 3 | $159 |
| Janssen Biotech, Inc. | 2 | $152 |
| Lilly USA, LLC | 5 | $142 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $138 |
Products named: OPZELURA, ADBRY, VTAMA, NEMLUVIO, Zoryve, DUPIXENT, LITFULO, TREMFYA.
Industry payments across CA — which companies pay providers there.
